Centiva Capital, LP Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $614,454 - $721,056	-600 Reduced 50.0%	600 $630,000
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $353,280 - $428,476	-400 Reduced 25.0%	1,200 $1.26 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $541,614 - $596,010	600 Added 60.0%	1,600 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.63 Million - $1.85 Million	-2,100 Reduced 67.74%	1,000 $878,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $346,225 - $422,185	500 Added 19.23%	3,100 $2.55 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $630,027 - $747,315	-900 Reduced 25.71%	2,600 $1.87 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $1.7 Million - $2.07 Million	2,500 Added 250.0%	3,500 $2.88 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $1.41 Million - $1.53 Million	-2,000 Reduced 66.67%	1,000 $721,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2.58 Million - $3.26 Million	-4,500 Reduced 60.0%	3,000 $2.07 Million
Q2 2022 Aug 17, 2022	SELL	$548.35 - $738.84 $548,350 - $738,840	-1,000 Reduced 11.76%	7,500 $4.43 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $4.4 Million - $5.17 Million	7,400 Added 672.73%	8,500 $5.94 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $597,828 - $738,067	1,100 New	1,100 $695,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $82,038 - $95,517	-300 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $12.6 Million - $17.4 Million	-42,000 Reduced 99.29%	300 $94,000
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $8.93 Million - $10.5 Million	24,000 Added 131.15%	42,300 $17.4 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $6.15 Million - $7.38 Million	18,300 New	18,300 $6.84 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account